相关实验视频
Updated: May 5, 2026

11:10
Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
16.9K
胰岛素样生长因子结合蛋白3和胰腺癌的发病率在一个嵌套的病例对照研究
Yasushi Adachi1,2, Masanori Nojima3, Yingsong Lin4
1Department of Gastroenterology and Hepatology, Sapporo Medical University, S-1, W-16, Chuo-ku, Sapporo, Hokkaido 060-8543, Japan.
Japanese journal of clinical oncology
|September 19, 2025
概括
自由胰岛素样生长因子结合蛋白3 (IGFBP3) 水平与胰腺癌风险增加有关. 这一发现表明,自由IGFBP3可能作为胰腺癌发展的生物标志物.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 类似胰岛素的生长因子 (IGFs) 是菌因子,而IGF结合蛋白3 (IGFBP3) 调节IGF活动.
- 了解IGF相关分子在胰腺癌中的作用对于风险评估至关重要.
研究的目的:
- 调查IGF1和IGFBP3血清水平与胰腺癌发病率之间的关联.
- 确定特定形式的IGF和IGFBP3是否与胰腺癌风险相关.
主要方法:
- 在日本协作队列研究中进行的一项前性,嵌套的病例控制研究.
- 从39,242名受试者的血清样本使用条件逻辑回归进行了分析.
- 根据IGF1和IGFBP3水平计算胰腺癌风险的几率比率 (OR).
主要成果:
- 自由IGFBP3 (IGFBP3-IGF1) 与胰腺癌风险有显著的关联 (P趋势=0.011).
- 在自由IGFBP3 (OR = 3.42) 的第三个三位数中观察到的风险最高.
- 总IGF1,自由IGF1和总IGFBP3与胰腺癌风险无关.
结论:
- 自由IGFBP3与患胰腺癌的风险增加显著相关.
- 这些发现表明,自由IGFBP3可能是胰腺癌的潜在生物标志物.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
Dipeptidyl Peptidase 4 Inhibitors
1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
Type I Diabetes III: Clinical Manifestations
31
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
31

